Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma
| Errataetall: |
CommentOn: JAMA. 2018 Apr 10;319(14 ):1473-1484. - PMID 29554174 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:319 |
|---|---|
| Enthalten in: |
JAMA - 319(2018), 14 vom: 10. Apr., Seite 1441-1443 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krishnan, Jerry A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 17.04.2018 Date Revised 02.12.2018 published: Print CommentOn: JAMA. 2018 Apr 10;319(14 ):1473-1484. - PMID 29554174 Citation Status MEDLINE |
|---|
| doi: |
10.1001/jama.2018.2029 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM282100601 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM282100601 | ||
| 003 | DE-627 | ||
| 005 | 20231225033141.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jama.2018.2029 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0940.xml |
| 035 | |a (DE-627)NLM282100601 | ||
| 035 | |a (NLM)29554261 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Krishnan, Jerry A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.04.2018 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA. 2018 Apr 10;319(14 ):1473-1484. - PMID 29554174 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Anti-Asthmatic Agents |2 NLM | |
| 650 | 7 | |a Bronchodilator Agents |2 NLM | |
| 650 | 7 | |a Muscarinic Antagonists |2 NLM | |
| 650 | 7 | |a Tiotropium Bromide |2 NLM | |
| 650 | 7 | |a XX112XZP0J |2 NLM | |
| 700 | 1 | |a Au, David H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA |d 1948 |g 319(2018), 14 vom: 10. Apr., Seite 1441-1443 |w (DE-627)NLM000006939 |x 1538-3598 |7 nnns |
| 773 | 1 | 8 | |g volume:319 |g year:2018 |g number:14 |g day:10 |g month:04 |g pages:1441-1443 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jama.2018.2029 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 319 |j 2018 |e 14 |b 10 |c 04 |h 1441-1443 | ||